While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately ...

Shares of Bio-Techne Corp. TECH advanced 1.43% to $47.37 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.17% to 7,445.72 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Irvine-based MDxHealth announced that it’s discontinuing its Resolve diagnostic test for UTIs and closing lab operations in Texas due to reimbursement challenges.

Wall Street closed slightly higher on Friday but shed the lion's share of earlier gains into the close. The Dow Jones Industrial Average rose 0.58%, while the benchmark S&P 500 advanced 0.37%. The ...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations ...